Tempus Expands Collaboration with Remix Therapeutics on RNA-Based Cancer Therapies
Healthcare Technology Report September 4, 2024
Tempus AI, a pioneer in precision medicine and artificial intelligence, has extended its partnership with Remix Therapeutics, a clinical-stage biotechnology company that specializes in the development of small...